JP2002505336A5 - - Google Patents

Download PDF

Info

Publication number
JP2002505336A5
JP2002505336A5 JP2000534566A JP2000534566A JP2002505336A5 JP 2002505336 A5 JP2002505336 A5 JP 2002505336A5 JP 2000534566 A JP2000534566 A JP 2000534566A JP 2000534566 A JP2000534566 A JP 2000534566A JP 2002505336 A5 JP2002505336 A5 JP 2002505336A5
Authority
JP
Japan
Prior art keywords
enoic acid
group
formula
compound
epi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000534566A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002505336A (ja
Filing date
Publication date
Priority claimed from GBGB9804861.4A external-priority patent/GB9804861D0/en
Application filed filed Critical
Publication of JP2002505336A publication Critical patent/JP2002505336A/ja
Publication of JP2002505336A5 publication Critical patent/JP2002505336A5/ja
Pending legal-status Critical Current

Links

JP2000534566A 1998-03-06 1999-03-08 コレン酸アミドおよびその医薬組成物 Pending JP2002505336A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9804861.4A GB9804861D0 (en) 1998-03-06 1998-03-06 Chemical compounds
GB9804861.4 1998-03-06
PCT/GB1999/000681 WO1999045024A1 (en) 1998-03-06 1999-03-08 Cholenic acid amides and pharmaceutical compositions thereof

Publications (2)

Publication Number Publication Date
JP2002505336A JP2002505336A (ja) 2002-02-19
JP2002505336A5 true JP2002505336A5 (cg-RX-API-DMAC10.html) 2006-05-11

Family

ID=10828156

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000534566A Pending JP2002505336A (ja) 1998-03-06 1999-03-08 コレン酸アミドおよびその医薬組成物

Country Status (15)

Country Link
US (1) US7235552B1 (cg-RX-API-DMAC10.html)
EP (1) EP1060188A1 (cg-RX-API-DMAC10.html)
JP (1) JP2002505336A (cg-RX-API-DMAC10.html)
KR (1) KR100690037B1 (cg-RX-API-DMAC10.html)
CN (1) CN1177860C (cg-RX-API-DMAC10.html)
AU (1) AU752992B2 (cg-RX-API-DMAC10.html)
CA (1) CA2319763C (cg-RX-API-DMAC10.html)
CZ (1) CZ298478B6 (cg-RX-API-DMAC10.html)
GB (1) GB9804861D0 (cg-RX-API-DMAC10.html)
HU (1) HUP0100854A3 (cg-RX-API-DMAC10.html)
IL (1) IL138137A (cg-RX-API-DMAC10.html)
NO (1) NO317378B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ506139A (cg-RX-API-DMAC10.html)
WO (1) WO1999045024A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA991841B (cg-RX-API-DMAC10.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2408751A1 (en) * 2000-05-11 2001-11-15 Robert Henry Hesse 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
EP1514874A1 (en) * 2003-07-28 2005-03-16 Schering Aktiengesellschaft Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis regulating medicaments and method for the preparation thereof
WO2009059239A2 (en) * 2007-11-02 2009-05-07 Mayo Foundation For Medical Education And Research REDUCING Aβ42 LEVELS AND Aβ AGGREGATION
CN108191846B (zh) 2008-12-04 2021-08-20 于崇曦 高穿透性组合物及其应用
US8987235B2 (en) 2011-05-17 2015-03-24 Wisconsin Alumni Research Foundation N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitamin D analogs and their uses
KR20140063616A (ko) 2011-07-20 2014-05-27 브라이엄 영 유니버시티 소수성 세라게닌 화합물 및 이를 포함하는 기구
BR112015023747B1 (pt) 2013-03-15 2023-04-18 Brigham Young University Uso de um composto antimicrobiano catiônico esteroide (csa) para a preparação de uma composição para tratar, reduzir, ou prevenir inflamação aguda ou crônica e/ou dor aguda ou crônica associada com uma doença ou um sintoma de doença
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
US9434759B1 (en) * 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
EP3275888B1 (en) * 2016-07-28 2019-09-25 Council of Scientific & Industrial Research Progesterone-cationic lipid hybrid as anticancer agent and the process of synthesis thereof
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
US12186328B2 (en) 2019-05-23 2025-01-07 Brigham Young University Use of CSA compounds to stimulate stem cells and hair growth
WO2023205801A2 (en) 2022-04-22 2023-10-26 Asteroid Therapeutics Steroidal compositions and methods of treating lipogenic cancers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1512326A (fr) 1964-03-27 1968-02-09 Roussel Uclaf Nouveaux stéroïdes azotés et procédé de préparation
US4217288A (en) * 1977-03-24 1980-08-12 Wisconsin Alumni Research Foundation Anti-vitamin D compounds
US4172076A (en) * 1977-04-04 1979-10-23 Diamond Shamrock Corporation Process for preparing steroidal acids and their intermediate derivatives
FR2426044A2 (fr) * 1978-05-19 1979-12-14 Wisconsin Research Foundation Derives de la vitamine d3 ayant une activite anti-vitamine d
GB8505862D0 (en) * 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
PL171580B1 (pl) * 1991-11-07 1997-05-30 Res Inst Medicine Chem Sposób wytwarzania nowych analogów witaminy D3 PL PL PL
JP3493037B2 (ja) * 1991-12-18 2004-02-03 中外製薬株式会社 22−オキサコレカルシフェロール誘導体とその製造方法
IL105050A0 (en) * 1992-03-27 1993-07-08 Lilly Co Eli Steroid derivatives
GB9309422D0 (en) * 1993-05-07 1993-06-23 Res Inst Medicine Chem Chemical compounds
WO1997042215A1 (en) * 1996-05-06 1997-11-13 Bionumerik Pharmaceuticals, Inc. Process for preparing 27-hydroxy cholesterol and related derivatives
EP1019059A4 (en) * 1997-01-24 2004-01-14 Univ California USE OF FXR, PPAR-ALPHA AND LXR-ALPHA ACTIVATORS TO RESTORE THE BARRIER FUNCTION, TO PROMOTE EPIDERMIS DIFFERENTIATION, AND TO PROLIFERATE

Similar Documents

Publication Publication Date Title
AU2024200257B2 (en) 1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
Larsson et al. A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen‐induced arthritis (CIA) without causing hypercalcaemia
RU2003107921A (ru) Селективные циклопептиды
DE69531990T2 (de) Bicyclischer lactaminhibitor des interleukin-1-beta-konvertierenden enzyms
RU2315772C2 (ru) Производные пептидов, содержащие тиазепиновую группу, для лечения гиперлипемических состояний
JP2002503673A5 (cg-RX-API-DMAC10.html)
JP2002544137A5 (cg-RX-API-DMAC10.html)
MXPA04009490A (es) Compuesto de acido carbamico que comprenden un enlace de piperazina como inhibidores de histona desacetilasa.
LV12350A (lv) Heptapeptida oksitocina analogi
EP0368388A3 (en) 3-Piperidinyl-1,2-benzisoxazoles
ES2313969T3 (es) Derivados de pleuromutilino con actividad antibacteriana.
KR20120125610A (ko) 시클로스포린 유사체
JP2005527479A5 (cg-RX-API-DMAC10.html)
JP2024533273A5 (cg-RX-API-DMAC10.html)
KR100369104B1 (ko) 성장호르몬의유리를촉진하는2-알킬트립토판함유-올리고펩티드화합물
CA2319763A1 (en) Cholenic acid amides and pharmaceutical compositions thereof
RU2004114229A (ru) Применение гидроксиолеиновой кислоты и родственных соединений при производстве лекарственных средств
EP0673388B1 (en) Double chain peptide compounds having hemoregulatory activity
RU2004119964A (ru) Промежуточные соединения для синтеза антагониста рилизинг-фактора лютеинизирующего гормона (lhrh), способ их получения и способ получения антагониста lhrh
US6444832B1 (en) Amino alcohol derivatives, method of producing said derivatives and medicaments containing them
WO1996008505A1 (de) Steroidester und -amide, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DD284027A5 (de) Verfahren zur herstellung von renininhibitoren
JP2006513229A (ja) 睡眠時無呼吸におけるソマトスタチンアナログの使用
SU1623131A1 (ru) 2-Окси-3,5-дихлор-N-[3-хлор-4-(4-Хлорнафтилокси-1)фенил]бензамид, обладающий активностью при гименолепидозе
JP2926168B2 (ja) 含硫黄化合物